Adam Dupuy, PhD
Introduction
The goal of my current research is to understand the role that somatic mutation plays in all aspects of tumor biology. Much of our work has made use of the Sleeping Beauty (SB) transposon system to engineer mouse cancer models in which somatic mutations are generated by transposon insertions. We and our collaborators have recently described a variety of tumor models using the approach, and these studies have identified many novel candidate cancer genes. The current work in my laboratory focuses on the genetics of hepatocellular carcinoma and T-cell leukemia. In addition, we have ongoing collaborative efforts to develop SB models of ovarian and endometrial cancer. Future work in the lab will focus on using our mouse models to address relevant questions encountered by oncologists in the clinic (e.g. metastasis, drug resistance).
Current Positions
- Associate Professor of Anatomy and Cell Biology
- Associate Professor of Pathology
Education
- BA in Biology and Chemistry, Central College, Pella, Iowa, United States
- PhD in Molecular, Cellular, Developmental Biology, and Genetics, University of Minnesota, Minneapolis, Minnesota, United States
- Postdoctoral Fellow, University of Minnesota Cancer Center, Minneapolis, Minnesota, United States
- Postdoctoral Fellow in Mouse Cancer Genetics, National Cancer Institute, Frederick, Maryland, United States
Graduate Program Affiliations
Research Interests
- Focusing on identifying the genetic changes that lead to cancer.
Selected Publications
- Schillo JL, Feddersen CR, Peplinski RM, Powell LS, Varzavand A, Stipp CS, Riordan JD, Dupuy AJ. (2024) Single-cell genomics analysis reveals complex genetic interactions in an in vivo model of acquired BRAF inhibitor resistance. NAR Cancer. Jan 11; 6(1):zcad061. DOI: 10.1093/narcan/zcad061. PMID: 38213996. PMCID: PMC10782916.
- Zhu EY, Schillo JL, Murray SD, Riordan JD, Dupuy AJ. (2023) Understanding cancer drug resistance with Sleeping Beauty functional genomic screens: Application to MAPK inhibition in cutaneous melanoma. iScience. Aug 31; 26(10):107805. DOI: 10.1016/j.isci.2023.107805. PMID: 37860756. PMCID: PMC10582486.
- Jiang Z, Ju Y, Ali A, Chung PED, Skowron P, Wang D-Y, Shrestha M, Li H, Liu JC, Vorobieva I, Ghanbari-Azarnier R, Mwewa E, Koritzinsky M, Ben-David Y, Woodgett JR, Perou CM, Dupuy A, Bader GD, Egan SE, Taylor MD, Zacksenhaus E. (2023) Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer. Nat Commun. Jul 18; 14(1):4313. DOI: 10.1038/s41467-023-39935-7. PMID: 37463901. PMCID: PMC10354065.
- Rogers, L. M., Wang, Z., Mott, S. L., Dupuy, A. J. & Weiner, G. J. (2020). A genetic screen to identify gain- and loss-of-function modifications that enhance T-cell infiltration into tumors. Cancer immunology research. DOI: 10.1158/2326-6066.CIR-20-0056. PMID: 32611665.
- Feddersen, C. R., Wadsworth, L. S., Zhu, E. Y., Vaughn, H. R., Voigt, A. P., Riordan, J. D. & Dupuy, A. J. (2019). A simplified transposon mutagenesis method to perform phenotypic forward genetic screens in cultured cells. BMC Genomics 20 (1) 497. DOI: 10.1186/s12864-019-5888-6. PMID: 31208320. PMCID: PMC6580595.
- Loeb, K. R., Hughes, B. T., Fissel, B. M., Osteen, N. J., Knoblaugh, S. E., Grim, J. E., Drury, T. J., Sarver, A., Dupuy, A. J. & Clurman, B. E. (2019). Insertional mutagenesis using the Sleeping Beauty transposon system identifies drivers of erythroleukemia in mice. Sci Rep 9 (1) 5488. DOI: 10.1038/s41598-019-41805-x. PMID: 30940846. PMCID: PMC6445099.
- Merritt, N. M., Fullenkamp, C. A., Hall, S. L., Qian, Q., Desai, C., Thomason, J., Lambertz, A. M., Dupuy, A. J., Darbro, B. & Tanas, M. R. (2018). A comprehensive evaluation of Hippo pathway silencing in sarcomas. Oncotarget 9 (60) 31620-31636. DOI: http://dx.doi.org/10.18632/oncotarget.25824. PMID: 30167083. PMCID: PMC6114978.
- Riordan, J. D., Feddersen, C. R., Tschida, B. R., Beckmann, P. J., Keng, V. W., Linden, M. A., Amin, K., Stipp, C. S., Largaespada, D. A. & Dupuy, A. J. (2018). Chronic liver injury alters driver mutation profiles in hepatocellular carcinoma in mice. Hepatology 67 (3) 924-939. DOI: 10.1002/hep.29565. PMID: 28961327. PMCID: PMC5826818.
- Ziyad, S., Riordan, J. D., Cavanaugh, A. M., Su, T., Hernandez, G. E., Hilfenhaus, G., Morselli, M., Huynh, K., Wang, K., Chen, J. N., Dupuy, A. J. & Iruela-Arispe, M. L. (2018). A Forward Genetic Screen Targeting the Endothelium Reveals a Regulatory Role for the Lipid Kinase Pi4ka in Myelo- and Erythropoiesis. Cell Reports 22 (5) 1211-1224. DOI: 10.1016/j.celrep.2018.01.017. PMID: 29386109. PMCID: PMC5828030.
- Rauckhorst, A. J., Gray, L. R., Sheldon, R. D., Fu, X., Pewa, A. D., Feddersen, C. R., Dupuy, A. J., Gibson-Corley, K. N., Cox, J. E., Burgess, S. C. & Taylor, E. B. (2017). The mitochondrial pyruvate carrier mediates high fat diet-induced increases in hepatic TCA cycle capacity. Molecular Metabolism 6 (11) 1468-1479. DOI: 10.1016/j.molmet.2017.09.002. PMID: 29107293. PMCID: PMC5681281.